Search results
AHA 23: SUPER LIPID
Author(s):
Alexander Fanaroff
Added:
5 months ago
Video
ESC 23: LODESTAR Trial
Author(s):
Myeong-Ki Hong
Added:
7 months ago
Video
Author(s):
Harriette Van Spall
,
Steven E Nissen
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular…
View more
Author(s):
Annapoorna Kini
Added:
1 year ago
ACC.23/WCC — Principle investigator of YELLOW III, Dr Annapoorna Subhash Kini(Mount Sinai Hospital, US) joins us to talk about the study that assessed the effect of evolocumab (Repatha) on coronary plaque morphology using intravascular imaging and gene expression analysis of peripheral blood mononuclear cells (PBMC) in 140 patients with stable CAD on maximally tolerated statin therapy …
View more
Author(s):
Ryotaro Yamada
,
Teruyoshi Kume
,
Hiroshi Okamoto
,
et al
Added:
2 years ago
Author(s):
Erin D Michos
Added:
1 year ago
ACC.23/WCC — Dr Erin D Michos, preventive cardiologist, (Johns Hopkins University School of Medicine, US) joined us in New Orleans to comment on the new data from the CLEAR-Outcomes trial, that looked at the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients with cardiovascular disease or those at high risk of developing it who are statin intolerant…
View more
ACC 2023: Late-Breaking Science Video Collection
Author(s):
Enoch Akowuah
,
Annapoorna Kini
,
Atul Verma
,
et al
Added:
1 year ago
Video Series
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Prof Nicolas Van Mieghem and Dr Joost Daemen return with their critical review series, View from the Thoraxcenter, to preview the most anticipated late-breaking and featured science trials of ACC.23.
Which trials have the potential to change practice? What are the key considerations for patient care and research? What is the context of the top trials of ACC?
Trials covered in detail include:
…
View more
Author(s):
Michael Honigberg
Added:
4 months ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation…
View more
William E Boden
Job title: Professor of Medicine
Author